Skip to content

“According to one study, from 2016 to 2020, pharmaceutical companies spent $577 billion in stock buybacks and dividends — $56 billion more than what they spent on all research and development over that same period of time.”

Is it true?

Misleadingaccording to Washington Post

Washington Post checked this claim on 17 August 2021.

“Lacks context”

  1. English

    Read the fact-check at Washington Post

Related

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: Data Commons (ClaimReview feed), with the fact-check of the newsroom named. Licence: CC BY 4.0. Factiz added the language, the verdict category and the grouping of the same claim.

The sources are the verdict.